Stock Chart

BSX

$42.60 -1.46%
Score: 62.4 HOLD
LEAPs: SELL $45
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $45
Premium: $7.09
Expiry: Sep 17, 2027
Target: $38
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.86x (vs SPY: 0.9x | vs QQQ: 0.8x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
Descending Triangle Bearish scenario quality 61/100
Measured-move target $41.75 (-2.0%) · apex ~4 bars ahead
Break direction historically ~even (52% up, n=87) — scenario shown, not a forecast
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and target are drawn on the chart below.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About BSX - Boston Scientific Corp.

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Key Statistics

Market Cap $63B
P/E Ratio 17.64

This BSX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track BSX's price movements with trendlines, gamma walls, and key support/resistance levels.